CA2027434C - Trousse pour le diagnostic des douleurs thoraciques des leur apparition - Google Patents

Trousse pour le diagnostic des douleurs thoraciques des leur apparition

Info

Publication number
CA2027434C
CA2027434C CA002027434A CA2027434A CA2027434C CA 2027434 C CA2027434 C CA 2027434C CA 002027434 A CA002027434 A CA 002027434A CA 2027434 A CA2027434 A CA 2027434A CA 2027434 C CA2027434 C CA 2027434C
Authority
CA
Canada
Prior art keywords
antibody
markers
antibodies
marker
kit
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CA002027434A
Other languages
English (en)
Other versions
CA2027434A1 (fr
Inventor
George Jackowski
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SPECTRAL DIAGNOSTICS Inc
Original Assignee
SPECTRAL DIAGNOSTICS Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=4146144&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CA2027434(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by SPECTRAL DIAGNOSTICS Inc filed Critical SPECTRAL DIAGNOSTICS Inc
Priority to CA002027434A priority Critical patent/CA2027434C/fr
Priority to US07/695,381 priority patent/US5290678A/en
Priority to GB9111965A priority patent/GB2248688B/en
Priority to DE4122886A priority patent/DE4122886C2/de
Priority to BE9100710A priority patent/BE1004994A5/fr
Priority to AU84757/91A priority patent/AU654672C/en
Priority to NZ239938A priority patent/NZ239938A/en
Priority to ES09102146A priority patent/ES2070658B1/es
Priority to AR91320837A priority patent/AR247634A1/es
Priority to JP3262301A priority patent/JP2628421B2/ja
Priority to ITMI912687A priority patent/IT1251682B/it
Priority to BR919104431A priority patent/BR9104431A/pt
Priority to CN91109633A priority patent/CN1036155C/zh
Priority to FR9112584A priority patent/FR2667944B1/fr
Priority to MX9101550A priority patent/MX9101550A/es
Priority to KR1019910017994A priority patent/KR0167564B1/ko
Publication of CA2027434A1 publication Critical patent/CA2027434A1/fr
Priority to US08420298 priority patent/US5604105B1/en
Priority to US08697690 priority patent/US5747274B1/en
Priority to US08/707,594 priority patent/US5744358A/en
Priority to US08735178 priority patent/US5710008B1/en
Publication of CA2027434C publication Critical patent/CA2027434C/fr
Application granted granted Critical
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6887—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • G01N2800/324—Coronary artery diseases, e.g. angina pectoris, myocardial infarction
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/97—Test strip or test slide
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/973—Simultaneous determination of more than one analyte
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/807—Apparatus included in process claim, e.g. physical support structures
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/807—Apparatus included in process claim, e.g. physical support structures
    • Y10S436/808—Automated or kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/807—Apparatus included in process claim, e.g. physical support structures
    • Y10S436/81—Tube, bottle, or dipstick

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

On divulgue une trousse pour le diagnostic rapide de la cause d'une douleur thoracique chez un patient dès l'apparition de cette dernière. La trousse d'essai comprend un réservoir pour recevoir et conserver un échantillon de sang ou de sérum du patient et au moins trois anticorps monoclonaux ou polyclonaux en suspension dans un transporteur. Chaque anticorps est complémentaire d'une protéine différente libérée par le muscle cardiaque au cours des premiers stades d'un infarctus du myocarde et est accompagné de réactifs correspondants qui réagissent indépendamment à chaque anticorps réagissant avec la protéine complémentaire. La réponse combinée des réactifs constitue le diagnostic de l'état du patient.
CA002027434A 1990-10-12 1990-10-12 Trousse pour le diagnostic des douleurs thoraciques des leur apparition Expired - Lifetime CA2027434C (fr)

Priority Applications (20)

Application Number Priority Date Filing Date Title
CA002027434A CA2027434C (fr) 1990-10-12 1990-10-12 Trousse pour le diagnostic des douleurs thoraciques des leur apparition
US07/695,381 US5290678A (en) 1990-10-12 1991-05-03 Diagnostic kit for diagnosing and distinguishing chest pain in early onset thereof
GB9111965A GB2248688B (en) 1990-10-12 1991-06-04 Diagnostic kit for diagnosing and distinguishing chest pain in early onset thereof
DE4122886A DE4122886C2 (de) 1990-10-12 1991-07-11 Diagnostischer Kit für die Diagnose und Charakterisierung von Brustschmerzen bei ihrem ersten Auftreten
BE9100710A BE1004994A5 (fr) 1990-10-12 1991-08-01 Trousse de diagnostic pour diagnostiquer et distinguer une douleur thoracique lors de sa premiere apparition.
AU84757/91A AU654672C (en) 1990-10-12 1991-09-25 Diagnostic kit for diagnosing and distinguishing chest pain in early onset thereof
NZ239938A NZ239938A (en) 1990-10-12 1991-09-25 Diagnosis of myocardial infarction using antibodies to proteins released by heart muscle
ES09102146A ES2070658B1 (es) 1990-10-12 1991-09-30 Dispositivo para diagnosticar y distinguir el dolor toracico en su fase inicial en pacientes con riesgo de angina o infarto de miocardio.
AR91320837A AR247634A1 (es) 1990-10-12 1991-10-03 Juego de diagnostico para diagnosticar y distinguir el dolor toracico en su fase inicial
JP3262301A JP2628421B2 (ja) 1990-10-12 1991-10-09 診断試験用キットおよびこれを用いる方法
ITMI912687A IT1251682B (it) 1990-10-12 1991-10-10 Insieme di elementi diagnostici per diagnosticare e distinguere il dolore toracico al primo insorgere.
BR919104431A BR9104431A (pt) 1990-10-12 1991-10-11 Estojo de teste de diagnostico
CN91109633A CN1036155C (zh) 1990-10-12 1991-10-11 诊断和识别胸痛早期发作的诊断盒
FR9112584A FR2667944B1 (fr) 1990-10-12 1991-10-11 Trousse et procede de diagnostic pour le diagnostic precoce des douleurs thoraciques.
MX9101550A MX9101550A (es) 1990-10-12 1991-10-11 Juego diagnostico para diagnosticar y distinguir el dolor toracico en su fase inicial
KR1019910017994A KR0167564B1 (ko) 1990-10-12 1991-10-12 초기발현 흉부 진통을 진단하고 식별하기 위한 진단용구
US08420298 US5604105B1 (en) 1990-10-12 1995-04-11 Method and device for diagnosingand distinguishing chest pain in early onset thereof
US08697690 US5747274B1 (en) 1990-10-12 1996-09-05 Method and device for diagnosing and distinguishing chest pain in early onset thereof
US08/707,594 US5744358A (en) 1990-10-12 1996-09-05 Method and device for diagnosing and distinguishing chest pain in early onset thereof
US08735178 US5710008B1 (en) 1990-10-12 1996-10-22 Method and device for diagnosing and distinguishing chest pain in early onset thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA002027434A CA2027434C (fr) 1990-10-12 1990-10-12 Trousse pour le diagnostic des douleurs thoraciques des leur apparition

Publications (2)

Publication Number Publication Date
CA2027434A1 CA2027434A1 (fr) 1992-04-13
CA2027434C true CA2027434C (fr) 1999-01-05

Family

ID=4146144

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002027434A Expired - Lifetime CA2027434C (fr) 1990-10-12 1990-10-12 Trousse pour le diagnostic des douleurs thoraciques des leur apparition

Country Status (15)

Country Link
US (1) US5290678A (fr)
JP (1) JP2628421B2 (fr)
KR (1) KR0167564B1 (fr)
CN (1) CN1036155C (fr)
AR (1) AR247634A1 (fr)
BE (1) BE1004994A5 (fr)
BR (1) BR9104431A (fr)
CA (1) CA2027434C (fr)
DE (1) DE4122886C2 (fr)
ES (1) ES2070658B1 (fr)
FR (1) FR2667944B1 (fr)
GB (1) GB2248688B (fr)
IT (1) IT1251682B (fr)
MX (1) MX9101550A (fr)
NZ (1) NZ239938A (fr)

Families Citing this family (90)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5710008B1 (en) * 1990-10-12 1999-09-07 Spectral Diagnostics Inc Method and device for diagnosing and distinguishing chest pain in early onset thereof
US5604105B1 (en) * 1990-10-12 1999-08-24 Spectral Diagnostics Inc Method and device for diagnosingand distinguishing chest pain in early onset thereof
WO1994003807A1 (fr) * 1992-08-03 1994-02-17 Gec-Marconi Limited Procede de separation
US5807752A (en) * 1992-09-11 1998-09-15 Boehringer Mannheim Corporation Assay using an unblocked solid phase with immobilized analyte binding partner
DE4243648A1 (de) * 1992-12-23 1994-07-07 Boehringer Mannheim Gmbh Verfahren zur Bestimmung von Herzmuskelnekrosen mittels Antikörper gegen das N-terminale Troponin I-Peptid
FR2701954B1 (fr) * 1993-02-23 1995-07-07 Pasteur Sanofi Diagnostics Composition stabilisée de troponine pour immunoessais et procédé de stabilisation de troponine pour immunoessais.
AU689777B2 (en) * 1993-05-17 1998-04-09 Fortron Bioscience, Inc. Assay for cardiac troponin I
CA2130280C (fr) * 1993-08-24 1999-08-31 Lilian Lee Methode de purification de la troponine i cardiaque
US5658801A (en) * 1994-05-03 1997-08-19 Spectral Diagnostics Inc. Medical test kit
WO1996010076A1 (fr) * 1994-09-28 1996-04-04 Spectral Diagnostics Inc. Anticorps monoclonal contre la troponine i cardiaque humaine
US5702905A (en) * 1994-09-28 1997-12-30 Spectral Diagnostics Monoclonal antibody to human ventricular myosin light chains
US5573957A (en) * 1994-09-28 1996-11-12 Spectral Diagnostics, Inc. Monoclonal antibody to human cardiac myoglobin
US6627404B1 (en) * 1995-04-18 2003-09-30 Biosite, Inc. Methods for improving the recovery of troponin I and T in membranes, filters and vessels
US5795725A (en) * 1995-04-18 1998-08-18 Biosite Diagnostics Incorporated Methods for the assay of troponin I and T and selection of antibodies for use in immunoassays
US6991907B1 (en) 1995-04-18 2006-01-31 Biosite, Inc. Methods for the assay of troponin I and T and complexes of troponin I and T and selection of antibodies for use in immunoassays
ATE281648T1 (de) 1995-04-18 2004-11-15 Biosite Diagnostics Inc Verfahren zum assay von troponin i und t und komplexen von troponin i und t und auswahl von antikörpern zur verwendung in immunoassays
FR2734267B1 (fr) * 1995-05-16 1997-08-01 Pasteur Sanofi Diagnostics Composition stabilisee de troponine pour immunoessais et procede de preparation d'une telle composition stabilisee
ATE279876T1 (de) * 1995-08-17 2004-11-15 Univ Duke Verfahren zur feststellung von reperfusion nach thrombolytischer therapie
WO1997008551A1 (fr) * 1995-08-31 1997-03-06 First Medical, Inc. Procedes et anticorps permettant la detection de creatine kinase
US6611634B2 (en) 1996-03-19 2003-08-26 University Of Utah Research Foundation Lens and associatable flow cell
JPH09304393A (ja) * 1996-05-15 1997-11-28 Ind Technol Res Inst 急性心筋梗塞診断キット
US5690103A (en) * 1996-06-20 1997-11-25 Groth; Torgny Lars Detection/exclusion of acute myocardial infarction using neural network analysis of measurements of biochemical markers
US6156521A (en) * 1997-12-19 2000-12-05 Biosite Diagnostics, Inc. Methods for the recovery and measurement of troponin complexes
US5834210A (en) * 1997-05-23 1998-11-10 Spectral Diagnostics, Inc. Stable troponin subunits and complexes
US6248869B1 (en) 1997-05-29 2001-06-19 Medical Analysis Systems, Inc. Troponin I forms and use of the same
US6210976B1 (en) 1997-06-10 2001-04-03 Medlyte Diagnostics, Inc. Methods for early detection of heart disease
US5961470A (en) * 1997-07-09 1999-10-05 Wagner; David A. Breath test for assessing hepatic function
US7384751B1 (en) * 1997-07-16 2008-06-10 Queen's University At Kingston Methods of diagnosing muscle damage
US6222619B1 (en) 1997-09-18 2001-04-24 University Of Utah Research Foundation Diagnostic device and method
US6475785B1 (en) 1997-12-18 2002-11-05 Spectral Diagnostics, Inc. Single-chain polypeptides comprising troponin I N-terminal fragments and troponin C
US6077676A (en) * 1997-12-18 2000-06-20 Spectral Diagnostics, Inc. Single-chain polypeptides comprising troponin I and troponin C
US6214629B1 (en) 1998-08-06 2001-04-10 Spectral Diagnostics, Inc. Analytical test device and method for use in medical diagnoses
US6171870B1 (en) 1998-08-06 2001-01-09 Spectral Diagnostics, Inc. Analytical test device and method for use in medical diagnoses
US6410341B1 (en) 1998-08-06 2002-06-25 Spectral Diagnostics, Inc. Analytical test device and method for use in medical diagnoses
US6432126B1 (en) * 1998-09-30 2002-08-13 C.R. Bard, Inc. Flexible vascular inducing implants
US7282369B2 (en) * 1998-10-02 2007-10-16 Ischemia Technologies, Inc. Tests for the rapid evaluation of ischemic states and kits
US20030215359A1 (en) * 1998-10-02 2003-11-20 Ischemia Technologies, Inc. Tests for the rapid evaluation of ischemic states and kits
US7070937B1 (en) 1998-10-02 2006-07-04 Ischemia Technologies, Inc. Marker useful for detection and measurement of free radical damage and method
US6475743B1 (en) 1998-10-02 2002-11-05 Ischemia Technologies, Inc. Marker useful for detection and measurement of free radical damage and method
US20050142613A1 (en) * 1998-10-02 2005-06-30 David Bar-Or Test for the rapid evaluation of ischemic states and kits
US7449338B2 (en) * 1998-10-02 2008-11-11 Ischemia Technologies, Inc. Tests for the rapid evaluation of ischemic states and kits
GB9827411D0 (en) 1998-12-11 1999-02-03 Axis Biochemicals Asa Dipstick assay
CA2263063C (fr) * 1999-02-26 2004-08-10 Skye Pharmatech Incorporated Methode pour diagnostiquer et distinguer les accidents vasculaires cerebraux et dispositifs de diagnostic utilises a cette fin
US6780606B1 (en) * 1999-02-26 2004-08-24 Synx Pharma, Inc. Method for diagnosing and distinguishing stroke and diagnostic devices for use therein
US7618782B1 (en) 1999-10-18 2009-11-17 Queen's University At Kingston Methods of diagnosing muscle damage
GB9929140D0 (en) * 1999-12-10 2000-02-02 Univ Geneve Diagnostic assay for stroke
US7078486B2 (en) * 1999-12-10 2006-07-18 Spectral Diagnostics, Inc. Single-chain polypeptides comprising troponin I and troponin C
DE60129674T2 (de) * 2000-03-10 2008-06-05 Université De Genève Verfahren zur diagnose von transmissiblen spongiformen encephalopathien
US7204847B1 (en) 2000-07-28 2007-04-17 C. R. Bard, Inc. Implant anchor systems
US6858590B2 (en) * 2000-08-17 2005-02-22 Tripep Ab Vaccines containing ribavirin and methods of use thereof
CN100400101C (zh) 2000-08-17 2008-07-09 特里帕普股份公司 包含病毒唑的疫苗及其使用方法
US6680059B2 (en) * 2000-08-29 2004-01-20 Tripep Ab Vaccines containing ribavirin and methods of use thereof
US7022830B2 (en) * 2000-08-17 2006-04-04 Tripep Ab Hepatitis C virus codon optimized non-structural NS3/4A fusion gene
CA2419295A1 (fr) * 2000-08-21 2002-02-28 Queen's University At Kingston Procedes et trousses pour la separation et la detection de proteines dans des echantillons biologiques
US6673562B2 (en) 2000-08-24 2004-01-06 Spectral Diagnostics, Inc. Differential immunoassay
US7632647B2 (en) * 2001-04-13 2009-12-15 Biosite Incorporated Use of B-type natriuretic peptide as a prognostic indicator in acute coronary syndromes
US7524635B2 (en) * 2003-04-17 2009-04-28 Biosite Incorporated Methods and compositions for measuring natriuretic peptides and uses thereof
US20040176914A1 (en) * 2001-04-13 2004-09-09 Biosite Incorporated Methods and compositions for measuring biologically active natriuretic peptides and for improving their therapeutic potential
US7713705B2 (en) 2002-12-24 2010-05-11 Biosite, Inc. Markers for differential diagnosis and methods of use thereof
US20030199000A1 (en) * 2001-08-20 2003-10-23 Valkirs Gunars E. Diagnostic markers of stroke and cerebral injury and methods of use thereof
US20030219734A1 (en) * 2001-04-13 2003-11-27 Biosite Incorporated Polypeptides related to natriuretic peptides and methods of their identification and use
EP1322957B1 (fr) * 2001-05-04 2009-08-12 Biosite Incorporated Marqueurs diagnostiques de syndromes coronaires aigus et leurs methodes d'utilisation
DE60233949D1 (de) * 2001-08-20 2009-11-19 Biosite Inc Diagnostische marker für schlaganfall und hirntrauma sowie verfahren zur verwendung davon
US7608406B2 (en) * 2001-08-20 2009-10-27 Biosite, Inc. Diagnostic markers of stroke and cerebral injury and methods of use thereof
US20040219509A1 (en) * 2001-08-20 2004-11-04 Biosite, Inc. Diagnostic markers of stroke and cerebral injury and methods of use thereof
US20040209307A1 (en) * 2001-08-20 2004-10-21 Biosite Incorporated Diagnostic markers of stroke and cerebral injury and methods of use thereof
US6461828B1 (en) 2001-09-04 2002-10-08 Syn X Pharma Conjunctive analysis of biological marker expression for diagnosing organ failure
US20030054414A1 (en) * 2001-09-17 2003-03-20 George Jackowski Diagnosis and treatment of early pre-type-1 diabetes utilizing glial fibrillary acidic protein
US20030162202A1 (en) * 2001-11-09 2003-08-28 Becker Kenneth David Single nucleotide polymorphisms and mutations on Alpha-2-Macroglobulin
US20040067512A1 (en) * 2001-11-09 2004-04-08 Neurogenetics, Inc. Single nucleotide polymorphisms and mutations on Alpha-2-Macroglobulin
US20040023309A1 (en) * 2001-11-27 2004-02-05 Franz Noll Immunoassay and kit for an early and simultaneous detection of biochemical markers in a patient's sample
JP4143756B2 (ja) * 2002-06-21 2008-09-03 財団法人名古屋産業科学研究所 心筋梗塞のリスク診断方法
GB0216191D0 (en) * 2002-07-11 2002-08-21 Univ Leicester Plasma urotensin in human heart failure
US20050014198A1 (en) * 2002-07-11 2005-01-20 Leong Ng Assays and kits for detecting and monitoring heart disease
GB0224425D0 (en) * 2002-10-21 2002-11-27 Univ Leicester Method for prediction of cardiac disease
WO2006032126A1 (fr) * 2004-09-24 2006-03-30 Syn X Pharma, Inc. Diagnostic et traitement du prediabete de type 1 au moyen de proteines neuronales
JP4727997B2 (ja) * 2005-01-12 2011-07-20 シスメックス株式会社 イムノクロマトグラフィー用キット
EP1888751A2 (fr) * 2005-05-25 2008-02-20 Tripep Ab Gene de fusion ns3/4a non structurel de l'hepatite c
CN101213451B (zh) * 2005-06-28 2013-04-03 Zbx公司 膜阵列和分析设备
CA2660286A1 (fr) * 2006-08-09 2008-02-21 Homestead Clinical Corporation Proteines specifiques d'organes et procedes d'utilisation
WO2009022236A2 (fr) 2007-08-16 2009-02-19 Tripep Ab Plate-forme immunogène
WO2009130588A2 (fr) * 2008-04-22 2009-10-29 Tripep Ab Plateforme immunogène
US20110076697A1 (en) * 2009-04-28 2011-03-31 Innovative Laboratory Technologies, Inc. Lateral-flow immuno-chromatographic assay devices
EP2427056A4 (fr) * 2009-05-07 2012-08-22 Univ Cincinnati Procédés permettant de prévenir la lésion ischémique par la stimulation d'un nocicepteur périphérique
US20110306148A1 (en) 2010-06-14 2011-12-15 Siemens Healthcare Diagnostics Inc. Composition for use as an assay reagent
CN103140755B (zh) 2010-07-22 2016-03-16 哈希公司 用于碱度分析的芯片上实验室
WO2012060845A1 (fr) * 2010-11-05 2012-05-10 University Of Cincinnati Méthodes pour prévenir la lésion ischémique par une stimulation nociceptive périphérique
CN110133277A (zh) 2011-09-08 2019-08-16 Nexus Dx股份有限公司 多级分析物检定
US9180449B2 (en) 2012-06-12 2015-11-10 Hach Company Mobile water analysis
USD768872S1 (en) 2012-12-12 2016-10-11 Hach Company Cuvette for a water analysis instrument

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5411231A (en) * 1977-06-27 1979-01-27 Daiichi Radioisotope Lab Production of purified antiimyoglobin antibody and quantitative analysis of myoglobin
US4353982A (en) * 1980-04-10 1982-10-12 Hoffmann-La Roche Inc. Immunochemical assay for creatine kinase-MB isoenzyme
US4624916A (en) * 1984-04-06 1986-11-25 International Immunoassay Laboratories, Inc. Process and composition for the rapid quantitation of small levels of creative kinase-MB isoenzyme
US4999285A (en) * 1984-11-15 1991-03-12 Syntex (U.S.A.) Inc. Chromatographic cassette
IE59210B1 (en) * 1985-11-14 1994-01-26 Univ Washington Creatine kinase mb determination method
JPS62151192A (ja) * 1985-12-24 1987-07-06 Denka Seiken Co Ltd ヒト心筋ミオシン軽鎖に対する単一クロ−ン抗体
DE3640318A1 (de) * 1986-11-26 1988-06-09 Boehringer Mannheim Gmbh Verfahren und testtraeger zur bestimmung eines analyten
DE3707746A1 (de) * 1987-03-11 1988-09-22 Boehringer Mannheim Gmbh Spezifische antikoerper gegen herzmuskelmyosin-leichtketten, ihre herstellung und verwendung in einem reagenz zur bestimmung von herzmuskelmyosin-leichtketten
CA1303983C (fr) * 1987-03-27 1992-06-23 Robert W. Rosenstein Essai en phase solide
US4857453A (en) * 1987-04-07 1989-08-15 Syntex (U.S.A.) Inc. Immunoassay device
CA1340557C (fr) * 1987-04-09 1999-05-25 Christine A. Vitkauskas Methode d'analyse pour ckmb et anticorps monoclonaux pour cette methode
CA1313616C (fr) * 1987-06-01 1993-02-16 Robert B. Sargeant Protocoles avec membranes non absorbantes a ecoulement lateral
US4900662A (en) * 1987-07-21 1990-02-13 International Immunoassay Laboratories, Inc. CK-MM myocardial infarction immunoassay
JPS6461664A (en) * 1987-08-18 1989-03-08 Maikurobaiorojikaru Res Corp Solid phase enzyme immunological inspection system and processing therefor
JPH01233298A (ja) * 1988-03-11 1989-09-19 Boehringer Mannheim Gmbh 抗体、その製造法、ｈｍｌｃを測定するための試薬、ならびにモノクローナル抗体
DE3814370A1 (de) * 1988-04-28 1989-11-09 Boehringer Mannheim Gmbh Testtraeger fuer die analyse einer probenfluessigkeit, verfahren zur durchfuehrung einer solchen analyse und herstellungsverfahren
JPH01302162A (ja) * 1988-05-31 1989-12-06 Tosoh Corp ヒトミオグロビンの測定方法
US5087556A (en) * 1989-05-17 1992-02-11 Actimed Laboratories, Inc. Method for quantitative analysis of body fluid constituents
GB8916718D0 (en) * 1989-07-21 1989-09-06 Vioclone Biolog Inc Use of creatine kinase and its isozyme ck-mb and human ventricular myosin light chain 1 in the diagnosis of heart failure

Also Published As

Publication number Publication date
DE4122886A1 (de) 1992-04-16
GB9111965D0 (en) 1991-07-24
KR0167564B1 (ko) 1999-03-30
DE4122886C2 (de) 2000-03-02
KR920008491A (ko) 1992-05-28
ITMI912687A1 (it) 1993-04-10
ES2070658A1 (es) 1995-06-01
NZ239938A (en) 1994-03-25
MX9101550A (es) 1992-07-08
BR9104431A (pt) 1992-06-09
BE1004994A5 (fr) 1993-03-16
AR247634A1 (es) 1995-01-31
JP2628421B2 (ja) 1997-07-09
FR2667944A1 (fr) 1992-04-17
JPH04258765A (ja) 1992-09-14
ITMI912687A0 (it) 1991-10-10
US5290678A (en) 1994-03-01
CN1060533A (zh) 1992-04-22
AU8475791A (en) 1992-04-16
ES2070658B1 (es) 1995-12-16
CA2027434A1 (fr) 1992-04-13
CN1036155C (zh) 1997-10-15
GB2248688B (en) 1995-07-12
GB2248688A (en) 1992-04-15
AU654672B2 (en) 1994-11-17
FR2667944B1 (fr) 1993-07-30
IT1251682B (it) 1995-05-19

Similar Documents

Publication Publication Date Title
US5290678A (en) Diagnostic kit for diagnosing and distinguishing chest pain in early onset thereof
EP1591789B1 (fr) Procédés permettant une meilleure récuperation de Troponine I et T
US5604105A (en) Method and device for diagnosing and distinguishing chest pain in early onset thereof
US5710008A (en) Method and device for diagnosing and distinguishing chest pain in early onset thereof
Watanabe et al. Development of a simple whole blood panel test for detection of human heart-type fatty acid-binding protein
Giuliani et al. Determination of cardiac troponin I forms in the blood of patients with acute myocardial infarction and patients receiving crystalloid or cold blood cardioplegia
US5914241A (en) Assays and kits for detecting analytes in the presence of cross-reacting substances
US20080311591A1 (en) Differential Immunoassay
Apple et al. Cardiac troponin, CK-MB and myoglobin for the early detection of acute myocardial infarction and monitoring of reperfusion following thrombolytic therapy
O’Regan et al. Direct detection of myoglobin in whole blood using a disposable amperometric immunosensor
CN112326975A (zh) 心肌肌钙蛋白i、脑利钠肽和d-二聚体胸痛三联免疫荧光定量检测试剂盒
US7202042B2 (en) Rapid evaluation of the ratio of biological molecules
Larue et al. Immunoradiometric assay of myosin heavy chain fragments in plasma for investigation of myocardial infarction
US4624916A (en) Process and composition for the rapid quantitation of small levels of creative kinase-MB isoenzyme
US6514716B1 (en) Detection of the end-position sialic acid groups of the human transferrin molecule
Panteghini et al. Rapid and specific immunoassay for cardiac troponin I in the diagnosis of myocardial damage
Apple Cardiac troponin I
Hamm Troponin T: a new marker for myocardial cell injury
Panteghini Clinical and analytical performance of automated immunochemiluminometric assays for determination of cardiac markers in serum
JP3308027B2 (ja) 一又はそれより多い被分析物質の免疫学的測定のための診断方法
McLellan Stratus cardiac specific troponin-I
Green CK-MB Measurements by Immunoassay
Rotenberg et al. Patterns of lactate dehydrogenase isoenzymes 1 and 2 in serum of patients performing an exercise test.

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry
MKEX Expiry

Effective date: 20101012